AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
12.61
-0.03 (-0.24%)
At close: Oct 13, 2026, 4:00 PM EDT
12.60
-0.01 (-0.08%)
After-hours: Oct 13, 2026, 7:57 PM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $4.09 billion as of October 13, 2026. It is the 4,212th most valuable company in the world and the 1,290th biggest in the United States. Its market cap has increased by 147.27% in one year.
Market Cap
4.09B
Enterprise Value
3.68B
1-Year Change
147.27%
Global Rank
Country Rank
#1,290 United States
Category
ChartMarket Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $4.09B, a decrease of -73.91%. That is a compound annual growth rate of -20.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 4.09B | 299.15% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 4.82B |
| Definium Therapeutics | 4.62B |
| Dianthus Therapeutics | 4.41B |
| Edgewise Therapeutics | 4.07B |
| Tango Therapeutics | 3.90B |
| Relay Therapeutics | 3.86B |
| Telix Pharmaceuticals | 3.61B |
| Legend Biotech | 3.44B |